1.
Chacón K, Mendivelso F, Gómez O, González C, Pinto D, Yama E, Moscoso E, Acevedo J, Bohórquez L, Rincón O, Ruiz P, Espitia Malagón R, Isaza M, Aroca G, Tovar H, Luján D, Rodríguez M, Hamann O, Yomayusa N. Comparative effectiveness and safety of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors in type 2 diabetes mellitus: rapid review of systematic reviews and meta-analyzes. Rev.ACE [Internet]. 2021 Jun. 14 [cited 2022 Jun. 29];7(4):222-34. Available from: https://revistaendocrino.org/index.php/rcedm/article/view/648